Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

USE OF ANATABINE TO TREAT INFLAMMATION AND METHODS OF SYNTHESIZING ANATABINE in WIPO Patentscope

This application claims priority to U.S. Application No. 61/439,483, filed February 4, 201 1 , U.S. Application No. 61/439,473, filed February 4, 2011 ; U.S. Application No. 61/384,447, filed September 20, 2010; U.S. Application No. 61/383,81 1 , filed September 1 7, 2010; and U.S. Application No. 12/729,346, filed March 23, 2010; the disclosure of each of which is hereby incorporated by reference in its entirety.

Excerpt:
" In some embodiments the disorder is brain swelling or a neurodegenerative disease such as multiple sclerosis, Alzheimer's disease, or Parkinson's disease. In other embodiments the disorder is inflammation related to a kidney disease, nephritis, glomerulonephritis, dialysis, peritoneal dialysis, pericarditis, chronic prostatitis, vasculitis, gout, or pancreatitis"

Patent description at:
http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2011119722&recNum=2&maxRec=21&office=&prevFilter=&sortOption=Pub+Date+Desc&queryString=FP%3A%28rock+creek+pharmaceuticals%29&tab=PCTDescription#